Atlas Trials

Phase 1

65,473 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 1

RecordFirmDate
A Study on Safety and Tolerability of SAR425899 in Overweight to Obese Subjects and Type 2 Diabetes Mellitus Patients Not Requiring Anti-Diabetic Pharmacotherapy With an Optional 6-month Safety Extension Period (NCT03414736)Sanofi2018-01-19
An Initial Safety Study of Gedatolisib Plus PTK7-ADC for Metastatic Triple-negative Breast Cancer (NCT03243331)Kathy Miller2018-01-19
A Study of ASN007 in Patients With Advanced Solid Tumors (NCT03415126)Asana BioSciences2018-01-19
Study Of Safety, Tolerability And Pharmacokinetics Of Subcutaneous Doses Of TA-46 (NCT04410809)Pfizer2018-01-19
Safety Tolerability DDI Short Course Treatment of LTBI Infection With High-dose Rifapentine and Isoniazid or Standard Isoniazid Preventive Therapy in HIV+ Patients (DOLPHIN & DOLPHIN TOO) (NCT03435146)The Aurum Institute NPC2018-01-18
GD2 Specific CAR and Interleukin-15 Expressing Autologous NKT Cells to Treat Children With Neuroblastoma (NCT03294954)Baylor College of Medicine2018-01-18
Single-Dose Study of MK-4250 Monotherapy in Anti-Retroviral Therapy-Naive, Human Immunodeficiency Virus (HIV)-1 Infected Participants (MK-4250-002) (NCT03351699)Merck Sharp & Dohme LLC2018-01-18
NasoShield Study of Safety and Immunogenicity (NCT03352466)Altimmune, Inc.2018-01-18
Effectiveness and Safety of Timolol and Dorzolamide Loaded Contact Lenses (NCT02852057)University of Florida2018-01-18
Gut Microbiota Transplantation in Systemic Sclerosis (NCT03444220)Oslo University Hospital2018-01-18
Chronic Convection Enhanced Delivery of Topotecan (NCT03154996)Columbia University2018-01-18
FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors (NCT03319459)Fate Therapeutics2018-01-18
ALS Treatment Extension Study (NCT03136809)Collaborative Medicinal Development Pty Limited2018-01-18
Carbonated Beverage Consumption in pH and Bacterial Proliferation (NCT05437874)Hospital Infantil de Mexico Federico Gomez2018-01-18
A Study of APR-246 in Combination With Dabrafenib in Resistant Patients With BRAF V600 Mutant Melanoma (NCT03391050)Aprea Therapeutics2018-01-18
TAA Specific Cytotoxic T Lymphocytes in Patients With Pancreatic Cancer (NCT03192462)Baylor College of Medicine2018-01-18
Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy (NCT03388619)National Cancer Institute (NCI)2018-01-17
Study of Gemcitabine, Nab-paclitaxel, and Ficlatuzumab (AV-299) in Patients With Advanced Pancreatic Cancer (NCT03316599)Dana-Farber Cancer Institute2018-01-17
This Study in Patients With Chronic Lymphocytic Leukaemia is Done to Determine a Safe and Effective Dose of BI 836826 in Combination With Venetoclax (NCT03343678)Boehringer Ingelheim2018-01-17
A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics (PK) of Nemiralisib (NCT03398421)GlaxoSmithKline2018-01-17
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of TAK-228 as Single Agent in Adult East Asian Participants With Advanced Nonhematological Malignancies (NCT03370302)Calithera Biosciences, Inc2018-01-17
Deep Brain Stimulation Surgery for Focal Hand Dystonia (NCT02911103)National Institute of Neurological Disorders and Stroke (NINDS)2018-01-17
UCDCC#271: Phase I/II Trial of Epacadostat, Intralesional SD101, Radiotherapy in Patients With Lymphoma (NCT03322384)University of California, Davis2018-01-17
Sofusa System With Sumatriptan (KC5010) Phase 1 Dose Escalation Safety and PK Study (KCC-SMT-002) (NCT03229798)Sorrento Therapeutics, Inc.2018-01-17
Safety of FURESTEM-CD Inj. in Patients With Moderate to Severe Plaque-type Psoriasis (NCT02918123)Kang Stem Biotech Co., Ltd.2018-01-17
A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema (NCT03397264)Opthea Limited2018-01-16
A Study of LAM-003 in Patients With Acute Myeloid Leukemia (NCT03426605)OrphAI Therapeutics2018-01-16
A Study of Lenvatinib Plus Nivolumab in Participants With Hepatocellular Carcinoma (NCT03418922)Eisai Co., Ltd.2018-01-16
Evaluating the Safety and Immunogenicity of ALVAC-HIV and MF59®- or AS01B-adjuvanted Bivalent Subtype C gp120 in Healthy, HIV-uninfected Adult Participants (NCT03122223)National Institute of Allergy and Infectious Diseases (NIAID)2018-01-16
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD5718 After Single and Multiple Ascending Dose Administration to Healthy Japanese Men (NCT03400488)AstraZeneca2018-01-16
Relacorilant Food Effect Study in Healthy Subjects (NCT03442621)Corcept Therapeutics2018-01-16
An Initial Study of AZD7325 in Adults With Fragile X Syndrome (NCT03140813)Children's Hospital Medical Center, Cincinnati2018-01-16
Dose Escalating Study of a Prototype CS6 Subunit Vaccine With a Modified Heat-labile Enterotoxin From Enterotoxigenic Escherichia Coli (ETEC) (NCT03404674)PATH2018-01-16
Minocycline for Alcohol Use Disorder (NCT03244592)University of California, Los Angeles2018-01-15
A Study of Sensitizing Potential of Diacerein 1% Ointment in Healthy Subjects (NCT03472547)Castle Creek Pharmaceuticals, LLC2018-01-15
A Safety and Efficacy Study of TALEN and CRISPR/Cas9 in the Treatment of HPV-related Cervical Intraepithelial NeoplasiaⅠ (NCT03057912)First Affiliated Hospital, Sun Yat-Sen University2018-01-15
Regorafenib and Nivolumab Simultaneous Combination Therapy (NCT03406871)Kohei Shitara2018-01-15
Safety, Dose Tolerance, Pharmacokinetics, and Pharmacodynamics Study of CPX-POM in Patients With Advanced Solid Tumors (NCT03348514)CicloMed LLC2018-01-15
Study of Lanadelumab in Healthy Japanese and Matched Caucasian Adult Subjects (NCT03401671)Shire2018-01-15
Neo-Adjuvant Bladder Urothelial Carcinoma COmbination-immunotherapy (NCT03387761)The Netherlands Cancer Institute2018-01-15
Single-Dose Bioequivalence Study Comparing Two 4 mg Nicotine Lozenges (NCT03432312)Fertin Pharma A/S2018-01-15
MSC Intratissular Injection in Crohn Disease Patients (NCT03901235)University of Liege2018-01-15
Use of a Prokinetic Agent as an Adjunct to Thrice Weekly Bowel Care After SCI (NCT04671030)James J. Peters Veterans Affairs Medical Center2018-01-15
Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NCT03247712)Providence Health & Services2018-01-15
A Drug-Drug Interaction Study Between Sotagliflozin and Ramipril (NCT03414723)Sanofi2018-01-15
A Study to Evaluate the Pharmacokinetics and Safety of ASC16 Tablets in Healthy Volunteers in China (NCT03430830)Ascletis Pharmaceuticals Co., Ltd.2018-01-15
A Study of LY3314814 in Healthy Participants (NCT03222427)AstraZeneca2018-01-15
Evaluation of an Ultra-speed Picosecond Laser for Treating Tattoos (NCT03386760)Centre Hospitalier Universitaire de Nice2018-01-15
Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors (NCT03387020)Pediatric Brain Tumor Consortium2018-01-13
Study of DS-8201a for Participants With Advanced Solid Malignant Tumors (NCT03383692)Daiichi Sankyo Co., Ltd.2018-01-12
Rucaparib and Irinotecan in Cancers With Mutations in DNA Repair (NCT03318445)Pamela Munster2018-01-12
This Study Tests BI 1467335 in Healthy Male Volunteers. The Study Tests How Different Doses of BI 1467335 Are Taken up and Handled by the Body (NCT03382509)Boehringer Ingelheim2018-01-12
A Study to Evaluate if ID-085 is Safe, Its Fate in the Body as Well as Its Potential Effects on the Body in Healthy Subjects (NCT03372629)Idorsia Pharmaceuticals Ltd.2018-01-12
A Bioequivalence Study of SKF101804 Cefixime Versus Cefixime Reference Formulation in Healthy Adults Under Fasting Conditions (NCT03329547)GlaxoSmithKline2018-01-11
GSK2983559 First Time in Human Study (NCT03358407)GlaxoSmithKline2018-01-11
Dopamine D2/D3 Receptor Upregulation by Varenicline in Methamphetamine Users (NCT03059563)University of California, Los Angeles2018-01-11
Clinical Study of ALT-P7 to Determine Safety, Tolerability and Pharmacokinetics in Breast Cancer Patients (NCT03281824)Alteogen, Inc.2018-01-11
A Clinical Trial to Evaluate the Safety and Pharmacokinetic (NCT03475719)Huons Co., Ltd.2018-01-11
The Tolerability and Pharmacokinetics Study of Kangdaprevir Sodium Tablet in Healthy Adult Subjects (NCT03811678)Sunshine Lake Pharma Co., Ltd.2018-01-11
Merestinib on Bone Metastases in Subjects With Breast Cancer (NCT03292536)University of Utah2018-01-11
Pevonedistat, Irinotecan, and Temozolomide in Treating Patients With Recurrent or Refractory Solid Tumors or Lymphoma (NCT03323034)Children's Oncology Group2018-01-11
4-way Crossover QT Evaluation in Healthy Subjects (NCT03709927)Nabriva Therapeutics AG2018-01-11
Safety and Tolerability of AAV8 Delivery of a Broadly Neutralizing Antibody in Adults Living With HIV: a Phase 1, Dose-escalation Trial (NCT03374202)National Institute of Allergy and Infectious Diseases (NIAID)2018-01-11
Glucophage Immediate Release (GIR) China Bioequivalence Study (NCT03393208)Merck KGaA, Darmstadt, Germany2018-01-10
Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care (NCT03371251)Boston Pharmaceuticals2018-01-10
Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Parkinson's Disease (NCT03550183)Hebei Newtherapy BIo-Pharma technology Co., Ltd.2018-01-10
Assessing the Safety and Tolerability of CSL730 in Healthy Caucasian and Japanese Adults (NCT03375606)CSL Behring2018-01-10
Neoadjuvant Avelumab and Hypofractionated Proton Radiation Therapy Followed by Surgery for Recurrent Radiation-refractory Meningioma (NCT03267836)Washington University School of Medicine2018-01-10
Probiotics, Respiratory and Intestinal Microbiome and Respiratory Tract Infections in Children (NCT03683927)Universidad Nacional Autonoma de Mexico2018-01-10
Comparative Bioavailability Study of Lamotrigine ER Tablets USP 50 mg (NCT05145608)Alembic Pharmaceuticals Ltd.2018-01-10
Pembrolizumab + Poly-ICLC in MRP Colon Cancer (NCT02834052)Asha Nayak2018-01-10
A Safety Study of SYNT001 in Participants With Warm Autoimmune Hemolytic Anemia (WAIHA) (NCT03075878)Alexion Pharmaceuticals, Inc.2018-01-10
Mutant p53-based Personalized Trial Using Decitabine and Arsenic Trioxide on AML/MDS (NCT03855371)Ruijin Hospital2018-01-10
ATRi Transition Rollover Study (NCT03309150)Merck KGaA, Darmstadt, Germany2018-01-10
A Trial to Assess the Safety and Efficacy of Topical Salbutamol in Healthy Volunteers. (NCT03514615)University Hospitals, Leicester2018-01-10
A Study to Evaluate the Denosumab in Healthy Adults (NCT03427853)Luye Pharma Group Ltd.2018-01-10
A Clinical Study of AK101 in Subjects With Moderate to Severe Plaque Psoriasis (NCT04172233)Akeso2018-01-09
This Study Tests How Healthy Men Tolerate Different Doses of BI 730357 and How the Metabolism of Midazolam is Affected by BI 730357 (NCT03279978)Boehringer Ingelheim2018-01-09
QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have Progressed (NCT03387111)ImmunityBio, Inc.2018-01-09
Optimizing Decision Making About Breast Reconstruction After Mastectomy: A Patient-Centered Approach (NCT03346161)Washington University School of Medicine2018-01-09
A 21 Day Irritation Study in Healthy Volunteers With Diacerein 1% Ointment (NCT03472534)Castle Creek Pharmaceuticals, LLC2018-01-09
Clinical Study to Investigate Effect of Macitentan on Riociguat Pharmacokinetics (NCT03389321)Actelion2018-01-09
Effect of Cimetidine on the Pharmacokinetics of Lucerastat in Healthy Subjects (NCT03380455)Idorsia Pharmaceuticals Ltd.2018-01-09
Immunotherapy With E6 T Cell Receptor (TCR) T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions (NCT03197025)National Cancer Institute (NCI)2018-01-09
Glasdegib in Refractory Patients With Sclerotic Chronic Graft-Versus-Host Disease (NCT03415867)Grupo Espanol de trasplantes hematopoyeticos y terapia celular2018-01-09
A Study to Investigate BMS-986165 and Methotrexate in Healthy Male Patients (NCT03402087)Bristol-Myers Squibb2018-01-08
Safety, Tolerability and Efficacy of the BL-8040 and Atezolizumab for Maintenance Treatment in Subjects With Acute Myeloid Leukemia (AML) (NCT03154827)BioLineRx, Ltd.2018-01-08
The Effect of Antioxidants on Skin Blood Flow-BH4 (NCT03680573)The University of Texas at Arlington2018-01-08
A 6-Week Study to Evaluate the Photoallergic Potential of Diacerein 1% Ointment in Healthy Volunteers (NCT03473197)Castle Creek Pharmaceuticals, LLC2018-01-08
Safety and Tolerability Trial (MVA-BN-Brachyury/FPV-Brachyury) (NCT03349983)Bavarian Nordic2018-01-08
Multiple Ascending Dose to Study the Safety, Tolerability, PK and PD Effects of AEF0117 (NCT03443895)Aelis Farma2018-01-08
Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) in Chronic Hepatitis B Patients (NCT04168333)Tasly Tianjin Biopharmaceutical Co., Ltd.2018-01-08
BioACL Reconstruction With Amnion Collagen Matrix Wrap and Stem Cells Case Series (NCT03294720)Andrews Research & Education Foundation2018-01-08
Statins and CPAP in Adipose Tissue of OSA (NCT03308578)Mayo Clinic2018-01-08
A Safety Surveillance Study in Subjects With Macular Degenerative Disease Treated With Human Embryonic Stem Cell-derived Retinal Pigment Epithelial Cell Therapy (NCT03167203)Astellas Institute for Regenerative Medicine2018-01-08
Sensitization Study of ATx201 in Healthy Volunteers (NCT03375957)UNION therapeutics2018-01-08
A Trial Comparing the Pharmacokinetic Properties of Fast-acting Insulin Aspart Between Children, Adolescents and Adults With Type 1 Diabetes (NCT03407599)Novo Nordisk A/S2018-01-08
Extragonadal Effects of hCG on Calcium Homeostasis (NCT03418896)Martin Blomberg Jensen2018-01-06
A Study to Evaluate the Safety and Pharmacokinetics of MEDI0382 in Overweight/Obese Subjects of Japanese or Chinese Descent (NCT03385369)MedImmune LLC2018-01-05
A Study to Investigate the Antidepressant Mechanism-of-action of JNJ-42847922 in Participants With Major Depressive Disorder (NCT03374475)Janssen Research & Development, LLC2018-01-05
← Previous Next →

Track Phase 1 automatically

Every clearance here is in the API, with alerts when new ones post.